After an emotional debate, the House gave the legislation final congressional approval by a largely party-line vote of 250-169, nine months after it passed the Senate. “This will provide fly-by-night physicians and clinics the opportunity to peddle false hope and ineffective drugs to desperate patients,” Pallone said. The bill does not require pharmaceutical firms to provide their experimental drugs to patients. It requires providers to give the FDA annual summaries of experimental drugs they’ve provided, rather than reporting within seven days of giving a product to a patient. In a letter Tuesday over 100 of them said the final legislation is worse.

Source: National Post May 22, 2018 21:32 UTC